CLINICIANS, INVESTORS AND REGULATORS UNITE TO SHAPE THE FUTURE OF AI IN WOMEN’S HEALTH
AI IN WOMEN’S HEALTH MOVES FROM HYPE TO REALITY AS SOLD-OUT LONDON SUMMIT BRINGS TOGETHER INDUSTRY LEADERS
Artificial intelligence is rapidly moving from research laboratories into real-world healthcare settings, and nowhere is its potential attracting greater attention than in women’s health.
On 25 June, clinicians, founders, regulators, investors and policymakers will gather at the London Institute for Healthcare Engineering for a sold-out summit examining how AI could help tackle some of the most persistent challenges in women’s healthcare while ensuring innovation is developed responsibly and equitably.
The event, titled AI × Women’s Health: Innovation, Challenges and Opportunities, has already reached full capacity, with all 140 places taken and a waiting list now in operation.
Organised by femtech company MEGI Health, the summit arrives at a pivotal moment for both artificial intelligence and women’s health.
Women’s Health Gains New Momentum
While AI capabilities continue to advance at remarkable speed, women’s healthcare is also receiving growing attention from investors, policymakers and entrepreneurs seeking to address long-standing disparities in diagnosis, treatment and clinical research.
According to analysis from the World Economic Forum and the McKinsey Health Institute, closing the global women’s health gap could add at least $1 trillion to the world economy annually by 2040.
Against this backdrop, the conference aims to showcase practical applications of AI already being developed and deployed across women’s healthcare while also addressing critical concerns around ethics, equity, privacy and data quality.
Dr Fran Conti-Ramsden, Clinician at Guy’s and St Thomas’ NHS Foundation Trust, Academic at King’s College London and Chief Medical Officer of MEGI Health, said: “Working at the intersection of clinical practice, academia and industry, I see both the tremendous challenges we face in delivering clinical care for women and the need for innovation, alongside the rapid development of AI and digital health technologies. But bringing innovation into clinical practice is fraught with challenges. I hope this day brings together people from across the landscape to discuss and define those challenges as well as celebrate progress in the field, sparking dialogue on how we should innovate responsibly, and to make sure women’s health is not left behind.”
Addressing The Data Gap Challenge
A major theme running throughout the event will be the importance of ensuring AI systems are built using representative data.
Historically, women have been under-represented in medical research and health datasets, creating concerns that future AI tools could inadvertently reinforce existing healthcare inequalities if these gaps are not addressed.
For many experts, solving the data challenge is critical if artificial intelligence is to deliver on its promise of more personalised and effective healthcare.
Nina Sesto, CEO of MEGI Health, said: “We are seeing a wave of innovation in women’s health, and AI has the potential to accelerate it. The opportunity is enormous, but it only pays off if these tools are built on representative data and designed around the realities of women’s health. That is exactly the conversation we wanted to convene, across clinicians, researchers, industry and regulators.”
From Research To Real-World Clinical Use
The summit programme reflects both the opportunities and challenges facing the sector.
Sessions will explore the use of AI in fetal and gynaecological ultrasound, maternal cardiovascular monitoring, clinical decision support and wider healthcare delivery.
Discussions will also examine how innovations can be safely adopted within the NHS and healthcare systems more broadly.
Among the speakers and session chairs are leading figures from healthcare, academia, regulation and technology, including Professor Eugene Oteng-Ntim, Professor Asma Khalil, Professor Richard Dobson, MiRa Jacobs of the MHRA, Professor Jane Hirst, Nell Thornton, Dr Alex Deng and representatives from several emerging health technology companies.
The Growing Influence Of Femtech
The event also highlights the growing momentum behind the UK’s femtech sector, which is increasingly positioning itself as a leader in addressing health challenges unique to women.
MEGI Health itself is developing a digital cardiovascular platform designed to support women throughout pregnancy, postpartum recovery and long-term cardiovascular care, an area receiving increased clinical attention as awareness grows around maternal heart health.
The convergence of AI, digital health and women’s healthcare is creating new opportunities for founders, investors and healthcare providers seeking to improve outcomes while reducing pressure on healthcare systems.
Building The Future Of Women’s Healthcare
As artificial intelligence continues to reshape healthcare globally, organisers hope the summit will help establish a stronger UK ecosystem around clinical AI in women’s health, bringing together expertise from medicine, research, technology, regulation and investment.
With AI adoption accelerating across healthcare, the conversations taking place in London this month could help shape how future technologies are developed, regulated and deployed, ensuring innovation serves the needs of women as effectively as it serves the broader healthcare sector.
